Medical Device Maker Broncus Gets Financial Breathing Room from IPO
Investors are betting company can quickly ramp up sales for its core pulmonary devices, most of which have been approved or are near approval in China, the U.S. and Europe
版權(quán)聲明：本文版權(quán)歸FT中文網(wǎng)所有，未經(jīng)允許任何單位或個人不得轉(zhuǎn)載，復(fù)制或以任何其他方式使用本文全部或部分，侵權(quán)必究。